| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Unknown |
| Molecule Category: | UKNOWN |
| UNII: | D6AT024T4P |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| DISRUPTING AGENT | Elongation factor 2 disrupting agent | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Adenocarcinoma of Lung | 2 | D000077192 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297777 |
| FDA SRS | D6AT024T4P |
CONTENTS